Objective: to obtain pilot data on efficacy and safety of clobazam adjunctive treatment of adults
Inclusion criteria
- Age 18-65
- Refractory focal epilepsy
- Past/current treatment with 4 AEDs. VNS allowed.
- Seizure frequency of ≥1/month
Contact
Mid-Atlantic Epilepsy & Sleep Center
Pavel Klein, M.D.
Ivana Tyrlikova, Arkady Barber, Lenka Goldman, study coordinators
Phone: 301 530 9744
Fax: 301 530 0046
